Diffuse Large B-Cell Lymphoma (DLBCL): Therapeutic Updates and Best Practices

Cost: Free

View Offer chevron_right


This free online CME program takes a deep look into Diffuse large B-cell lymphoma (DLBCL) and provides insights that will lead to better treatment for patients who suffer from the condition.

Topics covered in this CME activity include:,

  • Epidemiology and diagnosis of DLBCL
  • Management of DLBCL: current guidelines, agents, and monitoring
  • DLBCL Best practices


After completing thise course, you will better be able to:

  • Recognize and describe those characteristics that play a role in determining the staging, prognosis, and diagnosis of diffuse large B-cell lymphoma (DLBCL)
  • Describe the most approaches to DLBCL management and apply them to practice, taking into account the following: treatment modalities and the recent clinical trial evidence and evidence-based treatment guidelines supporting them
  • Summarize the risk-benefit profiles of current and emerging therapies for the treatment of DLBCL
  • Describe the challenges and barriers to care associated with treating patients with DLBCL


Target Audience: Hematologists and oncologists; physician assistants, nurse practitioners, nurses, and pharmacists who practice in oncology; and any other healthcare professionals with an interest in or who clinically encounter patients with DLBCL.

Stay up-to-date

Receive special offers, keep up with MOC requirements and stay informed of the latest offerings in free online CME in your specialty.